Guido Reger – författare

The internationalization of research and technology is one key component of the globalization of trade and business, with potentially major impacts on patterns of economic development and public policies worldwide. Particularly in the already highly globalized pharmaceutical industry, innovation processes have changed considerably in the last 15 - 20 years. One-dimensional, linear single-actor type processes are being replaced by multi-dimensional, complex, multi-actor schemes. As a consequence, new players are becoming more important, with biotechnology firms playing a key role. This study analyzes these new ways in drug development in pharmaceuticals within the concept of "national systems of innovations" as well as from the perspectives of different actors, and collects a lot of empirical evidence for the assumed type of changes, its repercussion on significant input measures and on the differing performance of national pharmaceutical industries.

The internationalization of research and technology is one key component of the globalization of trade and business, with potentially major impacts on patterns of economic development and public policies worldwide. Particularly in the already highly globalized pharmaceutical industry, innovation processes have changed considerably in the last 15 - 20 years. One-dimensional, linear single-actor type processes are being replaced by multi-dimensional, complex, multi-actor schemes. As a consequence, new players are becoming more important, with biotechnology firms playing a key role. This study analyzes these new ways in drug development in pharmaceuticals within the concept of "national systems of innovations" as well as from the perspectives of different actors, and collects a lot of empirical evidence for the assumed type of changes, its repercussion on significant input measures and on the differing performance of national pharmaceutical industries.

Das Buch behandelt die Effekte der Forschungs- und Technologieförderung der Europäischen Gemeinschaften (EG) für die deutsche Forschungslandschaft sowie die Wechselbeziehungen zwischen nationaler und europäischer Politik. Die Ergebnisse der Studie beruhen auf Analysen vorhandener Studien zum Thema, einer Datenbankanalyse, einer schriftlichen Befragung fast aller deutschen Teilnehmer am II. EG Rahmenprogramm und Experteninterviews. Das Buch kommt zu dem Ergebnis, daß die Forschungsprogramme der EG den Austausch von Ideen, Technologie und Wissen innerhalb der Europäischen Gemeinschaft fördern und die wissenschaftliche bzw. technologische Basis auch in Deutschland stärken. Die deutsche Forschungs- und Technologiepolitik hat ihre Bedeutung nicht verloren, die EG hat aber an Bedeutung gewonnen.

The book deals with the effects of the research and technological development (RTD) policy of the European Community (EC) on the German research landscape and the interactions between the EC and the German policy. A systematic attempt at a cross-programme and country specific level to examine these impacts empirically has not previously been undertaken. Viewed as a whole, the EC programmes promoted the exchange of ideas, technology and knowledge within the Community and strengthened the scientific and technical basis in Germany, although the national German RTD policy does not lose its predominant influence.

A more detailed understanding of the interaction between science and technology is necessary in order to develop appropriate tools for future R&D management and technology policy. The first part of this book describes the structure of the science/technology interface and analyses the role of science for the generation of new technologies and respective institutional problems. The second part examines the challenges to R&D management and appropriate management tools from the perspective of industrial enterprises. Part III documents the results of two field studies in the science-intensive areas of medical lasers and neural networks. The major aim of the book is to bring together the variety of different approaches from an academic and industrial perspective.

Global agierende Firmen wollen in den Schlüsselzentren der Welt exzellentes Wissen erschließen und verfügbar machen. Die Koordination dieser Innovationsprozesse stellt jedoch die Organisationsfähigkeit mancher Unternehmen auf eine harte Probe. Das Buch wendet sich an alle Interessierten in der Managementforschung und an Manager, die das Gestalten länderübergreifender Innovationsprozesse als Chance und nicht als "Alptraum" verstehen. Der Leser erfährt, nach welchen Kriterien die Innovationsprozesse international tätiger Unternehmen situationsgerecht gesteuert werden können. Grundlage sind vier detaillierte Unternehmensfallstudien und viele Interviews bei 18 internationalen Konzernen aus Westeuropa und Japan. An Beispielen werden neue laterale Organisationsformen für innovationsorientierte Unternehmen aufgezeigt.